Commentary: Chagas disease: 100 years since discovery and lessons for the future

International Journal of Epidemiology

Volumn 37, Issue 4, 2008, Pages 698-701

  Gürtler, Ricardo E ^a   Diotaiuti, Liléia ^b   Kitron, Uriel ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX; ORGANOCHLORINE INSECTICIDE; PYRETHROID;

BLOOD TRANSFUSION; CHAGAS DISEASE; DISEASE CARRIER; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION RATE; INSECTICIDE RESISTANCE; LIFE EXPECTANCY; MALARIA CONTROL; NONHUMAN; NOTE; PARASITE CONTROL; PARASITE TRANSMISSION; PRIORITY JOURNAL; SERODIAGNOSIS; TRIATOMA INFESTANS; TRYPANOSOMA CRUZI;

BRAZIL; CHAGAS DISEASE; FORECASTING; HISTORY, 20TH CENTURY;

EID: 48349098874     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn134     Document Type: Note

References (22)

1. Chagas C. Nova tripanozomiaze humana. Estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen.,n.sp., agente etiologico de nova entidade morbida do homem - Ueber eine neue Trypanosomiasis des Menschen. Studien über Morphologie und Entwicklungszyklus des Schizotrypanum cruzi n. gen., n. sp., Erreger einer neuen Krankheit des Menschen. Mem Inst Oswaldo Cruz 1909;1:159-218.
2. Cohen JE. Human population: The next half century. Science 1995; 302:1172-75.
3. Cohen JE. Population and planet: The twentieth century and the twenty-first. Harv Mag 1999;102:38-40.
4. Lewinsohn R. Prophet in his own country. Carlos Chagas and the Nobel Prize. Perspect Biol Med 2003;46:532-49.
5. Morel CM. Chagas disease, from discovery to control - and beyond: History, myths and lessons to take home. Mem Inst Oswaldo Cruz 1999;94(Suppl I):3-16.
6. Wendel S, Brenner Z. Historical aspects. In: Wendel S, Brener Z, Camargo ME, Rassi A (eds). Chagas Disease (American Trypanosomiasis): Its impact on Transfusion and Clinical Medicine. Sao Paulo: International Society for Blood Transfusion, 1992. pp. 5-12.
7. Dias E, Pellegrino J. Alguns ensaios com o gammexane no combate aos transmissores da doença de Chagas. Brasil Méd 1948;62 185-91.
8. Romaña C, Abalos JW. Acción del 'Gammexane' sobre los triatomideos. 'Control' domiciliario. An Inst Med Reg (Tucumán) 1948;2:95-106.
9. World Health Organization. World Health Report 2004: Changing History Geneva: World Health Organization, 2004. Available at: http://www.who.int/whr/2004/en/ (Accessed May 30, 2007).
10. Dias JCP, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: A review. Mem Inst Oswaldo Cruz 2002; 97:603-12.
11. Silveira AC. El control de la enfermedad de Chagas en los países del Cono Sur de América. Historia de una iniciativa internacional. 1991-2001. In: Silveira AC, Rojas de Arias A, Guillén G, Russomando G, Schenone H (eds). Uberaba: Facultad de Medicina do Triangulo Mineiro, 2002.
12. Division of Control of Tropical Diseases. Chagas Disease: A Disease whose Days are Numbered. Geneva: World Health Organization, 1996.
13. World Health Organization. Control of Chagas Disease. Geneva: World Health Organization, 2002.
14. Anonymous. New global effort to eliminate Chagas disease. Partners set out strategy against the 'kissing bug' disease. Available at: http://www.who.int/mediacentre/news/releases/2007/pr36/en/index.html (Accessed December 27, 2007).
15. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol 2006;22:583-88.
16. Gürtler RE, Kitron U, Cecere MC, Segura EL, Cohen JE. Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina. Proc Natl Acad Sci USA 2007;104:16194-99.
17. Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005;18:12-29.
18. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gürtler RE. The challenges of Chagas disease - grim outlook or glimmer of hope. PLoS Med 2007;4:1852-57.
19. Viotti R, Vigliano C, Lococo B et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial. Ann Intern Med 2006;144 724-34.
20. Rassi A Jr, Rassi A, Little WC et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006;355:799-808.
21. Yadón ZE, Gürtler RE, Tobar F, Medici AC. Decentralization and Management of Communicable Disease Control in Latin America. Buenos Aires: Pan American Health Organization, 2007. AHailable at: http://www.paho.org/English/ad/dpc/cd/ res-descentralizacion.htm (Accessed November 4, 2007).
22. Gürtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis 2003;9:29-32.